𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: A study in a real life population

✍ Scribed by Katrien Van Puyvelde; Tony Mets; for the RODOS Study Group

Book ID
109005596
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
112 KB
Volume
11
Category
Article
ISSN
1444-1586

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety and tolerability of once-daily ve
Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease
✍ Roy W. Jones; Antony Bayer; Fraser Inglis; Andrew Barker; Ravinder Phul πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 1 views

## Abstract ## Objective To assess the safety and tolerability of three different dosing schedules of memantine in patients with moderate to severe Alzheimer's disease (AD). ## Method This 12‐week, randomised, double‐blind study, investigated three dosing schedules of memantine: OD1 (20 mg once

A multinational, randomised, 12-week stu
A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease
✍ Roy W. Jones; Hilkka Soininen; Klaus Hager; Dag Aarsland; Peter Passmore; Anita πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 180 KB πŸ‘ 2 views

## Abstract ## Objectives To compare directly, in the same patient cohort, the ease of use and tolerability of donepezil and galantamine in the treatment of Alzheimer's disease (AD), and investigate the effects of both treatments on cognition and activities of daily living (ADL). ## Methods Pati